NanoHorizons -
[Cached Version]
Published on: 1/18/2008
Last Visited: 1/18/2008
Joseph D. Cuiffi, Ph.D. | James Delattre, Ph.D. | Ned Satterfield | Stephen Fonash, Ph.D. | Robert F. Burlinson, M.B.A, C.P.A. | Edward Frymoyer, Ph.D. | Suresh Mahajan, Ph.D. | Peter M. Fonash, Ph.D.
...
Suresh Mahajan, PhD.
Was Chief Medical Officer and Vice President of R&D of Catalytica, Inc., a successful biotechnology company that was sold in 2000 for $800 million; led development of catalytic technology platform for the pharmaceutical industry that was led to Catalytica's growth from start-up to $400 million in revenue in 5 years; over 30 years of experience in discovery and development of new technology in the pharmaceutical and chemical industries; PhD. in chemical engineering from Purdue University.